Abstract
The introduction of the pneumococcal conjugated vaccines (PCVs) resulted in a substantial reduction of invasive pneumococcal disease (IPD) rates. However, impact on nonsevere IPD (mostly occult bacteremia) has not yet been fully elucidated. We assessed severe and nonsevere IPD (SIPD and NSIPD, respectively) rate dynamics in children < 5 years in Israel before and after PCV7/PCV13 implementation. A prospective, population-based, nationwide surveillance. All IPD episodes recorded from 1999 through 2015 were included. NSIPD was defined as IPD episodes without meningitis, pneumonia or mastoiditis in a child with a favorable outcome (not hospitalized or hospitalized in a nonintensive care unit < 5 days, without mortality). Three subperiods were defined: pre-PCV (1999-2008), PCV7 (2010-2011) and PCV13 (2013-2015). Incidence rate ratios (IRRs) were calculated. Overall, 4,457 IPD episodes were identified; 3,398 (76.2%) SIPD, 1,022 (22.9%) NSIPD and 37 (0.8%) unknown. In 90% of NSIPD episodes, no focus was identified. In the PCV7 period, NSIPD rates significantly declined by 52%, while SIPD rates declined less prominently by 24%. Following PCV13 introduction, compared with the PCV7 period, NSIPD rates declined nonsignificantly by 17% wh...Continue Reading
References
Mar 1, 1997·Pediatrics·S G RothrockJ L Falk
Jan 12, 2000·Pediatric Clinics of North America·N Kuppermann
Nov 30, 2000·Annals of Emergency Medicine·L J Baraff
Jun 27, 2003·Lancet·Xavier Sáez-Llorens, George H McCracken
Jul 9, 2004·Archives of Pediatrics & Adolescent Medicine·Matthew L Stoll, Lorry G Rubin
Mar 29, 2006·The Pediatric Infectious Disease Journal·Arnd M HerzHenry R Shinefield
Mar 6, 2007·Annals of Emergency Medicine·Keri L CarstairsRobert H Riffenburgh
Jan 13, 2009·Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine·Matthew WilkinsonMatthew Smith
Sep 15, 2009·Lancet·Katherine L O'BrienUNKNOWN Hib and Pneumococcal Global Burden of Disease Study Team
Jun 10, 2010·Pediatric Emergency Care·Mark D Joffe, Elizabeth R Alpern
Sep 29, 2011·Acta Paediatrica·Silvia BressanLiviana Da Dalt
Jul 6, 2012·Clinical Microbiology Reviews·Tina Q Tan
Sep 4, 2012·Vaccine·S Ben-ShimolUNKNOWN Israeli Bacteremia and Meningitis Active Surveillance Group
Mar 25, 2014·Vaccine·Albert Jan van HoekElizabeth Miller
Apr 3, 2014·Vaccine·Shalom Ben-ShimolRon Dagan
Nov 8, 2014·Acta Paediatrica·Susanna Hernandez-BouCarles Luaces
Mar 13, 2015·The Pediatric Infectious Disease Journal·Shalom Ben-ShimolUNKNOWN Israeli Bacteremia and Meningitis Active Surveillance Group
Jan 8, 2016·Pediatrics and Neonatology·Haya Ribitzky-EisnerEugene Leibovitz
Aug 1, 2016·Vaccine·S Ben-ShimolUNKNOWN Israel Bacteremia and Meningitis Active Surveillance Group
Jun 6, 2017·Vaccine·Shalom Ben-ShimolUNKNOWN Israel Bacteremia and Meningitis Active Surveillance Group
Jun 25, 2017·Vaccine·I YildirimUNKNOWN he Massachusetts Dept. of Public Health
Jul 19, 2017·Vaccine·Romina CamilliUNKNOWN Pneumococcal Surveillance Group
Feb 6, 2018·The Lancet Infectious Diseases·Shamez N LadhaniMary E Ramsay
Feb 21, 2018·Emerging Infectious Diseases·Assaf RokneyLea Valinsky
Citations
Mar 15, 2019·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Corinne LevyRobert Cohen
Dec 1, 2019·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Joseph A LewnardRon Dagan
Mar 7, 2020·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Ron DaganNoga Givon-Lavi
Apr 16, 2019·Therapeutic Advances in Infectious Disease·Enrique Chacon-CruzJorge Arturo Alvelais-Palacios
Oct 12, 2019·Pathogens·Guido CamanniSusanna Esposito
Feb 8, 2020·Allergy & Rhinology·Charles H SongRichard Stiehm
Jan 7, 2021·Allergy & Rhinology·Diana ChernikovaCharles H Song
Sep 19, 2021·Acta Paediatrica·Guy HazanRaouf Nassar